食管胃结合部腺癌根治术的前瞻性评估:CLAEG研究真实世界洞察
CLAEG研究前瞻性纳入中国44个中心2044例食管胃结合部腺癌根治性切除术患者,分析淋巴结转移模式及手术结局。结果显示腹部淋巴结转移率显著高于纵隔,新辅助治疗、全胃切除术和腹腔镜手术与良好短期结局相关。
要点
- 腹部淋巴结转移率高于纵隔,应优先行腹部淋巴结清扫。
- 新辅助治疗可降低淋巴结转移率,提示降期效应。
- 全胃切除较近端胃切除并发症更低,腹腔镜恢复更快且不增加并发症。
核心结论
- 食管胃结合部腺癌应优先进行腹部淋巴结清扫,新辅助治疗、全胃切除术和腹腔镜手术与良好的短期结局相关。
研究设计与样本
- CLAEG登记研究,2022年启动,中国44个高容量中心前瞻性入组,本分析纳入2044例根治性切除术患者。
主要发现
- 大多数肿瘤为Siewert II型(64.6%)或III型(33.4%)。
- 腹部淋巴结转移率显著高于纵隔,第1类淋巴结(转移率>10%)包括第1、2、3、4、7、8a、9和11p站。
- 纵隔淋巴结转移率分别为第110站2.77%、第111站0.71%、第112站0.68%。
- 接受新辅助治疗的患者淋巴结转移率更低,提示淋巴结降期。
- 全胃切除术较近端胃切除术术后并发症率更低(14.8% vs 21.0%;p=0.001),且淋巴结清扫更广泛。
关键数值与推荐
- 第1类淋巴结(转移率>10%)包括第1、2、3、4、7、8a、9和11p站。
- 纵隔淋巴结转移率:第110站2.77%,第111站0.71%,第112站0.68%。
- 全胃切除与近端胃切除并发症率:14.8% vs 21.0%(p=0.001)。
- 腹腔镜与开放手术并发症率:16.5% vs 17.3%。
临床怎么用
- 对于食管胃结合部腺癌根治术,应优先进行腹部淋巴结清扫。
- 新辅助治疗可考虑用于降低淋巴结转移率。
- 全胃切除术可能降低术后并发症率,腹腔镜手术可加速术后恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal surgical strategy for adenocarcinoma of oesophagogastric junction (AEG) remains debated, particularly regarding lymphadenectomy extent, gastrectomy type and surgical approach, with real-world prospective evidence being scarce. OBJECTIVE: To map lymph node metastasis (LNM) patterns and assess surgical outcomes in a large multicentre cohort of patients with AEG undergoing radical resection. DESIGN: The Chinese League of Adenocarcinoma of Esophagogastric Junction (CLAEG) registry, initiated in 2022 across 44 high-volume Chinese centres, prospectively enrolled AEG patients. This analysis included 2044 radical resections, with LNM assessed by station, stratified by Siewert type and neoadjuvant therapy. Surgical outcomes were compared between total versus proximal gastrectomy and laparoscopic versus open resection. RESULTS: Most tumours were Siewert type II (64.6%) or III (33.4%). LNM was substantially higher in abdominal than mediastinal stations; category-1 nodes (metastasis, >10%) comprised stations 1, 2, 3, 4, 7, 8a, 9 and 11p. The LNM rates for mediastinal stations were 2.77% (No. 110), 0.71% (No. 111) and 0.68% (No. 112). Patients who received neoadjuvant therapy had lower LNM rates, indicating nodal downstaging. Among those undergoing gastrectomy, patients who underwent total gastrectomy had a lower postoperative complication rate than those who underwent proximal gastrectomy (14.8% vs 21.0%; p=0.001) and achieved more extensive lymphadenectomy. Compared with open surgery, patients who underwent laparoscopic resection experienced faster postoperative recovery without higher complication rates (16.5% vs 17.3%). No perioperative mortality occurred. CONCLUSION: The CLAEG study shows that abdominal lymphadenectomy should be prioritised in AEG, with neoadjuvant therapy, total gastrectomy and laparoscopy associated with favourable short-term outcomes.
引用
- Zheng J, Li Y, Fan L, et al. Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study. Gut. 2026. PMID: 41611521. doi:10.1136/gutjnl-2025-337393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。